Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BioVitrum/Amgen: A Sign of Early-Stage Deals to Come

Oct 01 2003

Related Content

Alizyme/Takeda: Japan Deals Gather Steam

Sep 01 2003

Tularik & Amgen: A Model of Business Development (and Good News for Biotech, Too)

Jun 01 2003

Zealand Deals Diabetes Drug to Aventis

Jul 01 2003

Amylin/Lilly: Resurrections and Conversions

Oct 01 2002

Why Pharma Needs to Do Early-Stage Deals

Sep 01 2002

Related Companies

Sanofi

Amgen, Inc.

Regeneron Pharmaceuticals, Inc.

Swedish Orphan Biovitrum AB

Pfizer Inc.

Takeda Pharmaceutical Co. Ltd.

GSK plc

Bristol Myers Squibb Company

Avadel Pharmaceuticals plc

QDose Ltd.

Bristol Myers Squibb Company

Zealand Pharma A/S

Novo Nordisk A/S

Novartis AG

Amgen, Inc.

NPS Pharmaceuticals, Inc.

Array BioPharma, Inc.

Additional Topics

BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window